Drugs / Measles, mumps, and rubella (MMR) vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07195032 | Sep 2025 → Sep 2027 expected | transplant-related bronchiolitis obliterans | Children's Mercy Hospital Kansas City | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles, mumps, and rubella (MMR) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07195032 ↗ |
| Known as | MMR vaccine | “live Measles, Mumps and Rubella (MMR) vaccine” NCT07195032 ↗ |
| Modality | Vaccine | “live Measles, Mumps and Rubella (MMR) vaccine” NCT07195032 ↗ |